MimeCure
PrivateLast Round
Debt
Jan 1, 2026
Total Funding Raised
$220,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MimeCure is a biotechnology company developing a first-in-class regenerative therapy for chronic and progressive lung diseases, with an initial focus on idiopathic pulmonary fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD).
Sector
Cybersecurity
Verticals
Email Security, Cloud Security, Data Protection, Threat Intelligence, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MimeCure Comparables
Compare MimeCure with similar companies based on industry and business-model similarity.
MimeCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jan 1, 2026 | ||||
| Grant | Dec 1, 2025 | ||||
| VC Round | Nov 1, 2024 | ||||
| Grant | Oct 23, 2024 |
MimeCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Netherlands Organization for Scientific Research | Debt |
| Pharma Connect Capital | VC Round |
| Longfonds | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Secured debt financing from Netherlands Organization for Scientific Research.
- Dec 1, 2025
Received grant funding from Longfonds.
MimeCure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MimeCure's valuation, stock price, and market status.